X4 Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $107,522,000.

Profit Margin

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR): Profit margin
2015 0 -13.21M
2016 0 -22.97M
2017 0 -33.87M
2018 3.5M -43.02M -1229.17%
2019 0 -56.60M
2020 3M -62.13M -2071.03%
2021 0 -88.69M
2022 0 -93.86M
2023 0 -101.16M

XFOR Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0003M03.5M000
Cost of revenue
1.99M1.99M1.89M0672K0195K0400K
Gross profit
-1.99M-1.99M-1.89M3M-672K3.5M-195K0-400K
Operating exp.
Research and development
72.01M61.05M50.64M41.93M30.16M30.97M28.12M17.83M12.70M
Selling and marketing
000000000
Total operating expenses
107.52M88.07M75.34M62.87M47.80M46.20M32.26M21.95M12.67M
Operating income
-107.52M-87.56M-85.10M-59.87M-51.70M-45.88M-36.13M-24.34M-14.82M
Other income (expenses), net
6.43M-6.27M-3.57M-2.10M-1.10M-85K2.25M1.49M1.60M
Income before tax
-101.08M-93.83M-88.67M-61.98M-52.80M-43.02M-33.87M-22.97M-13.21M
Income tax expense
78K28K17K148K3.79M3.90M1.86M2.61M395K
Net income
-101.16M-93.86M-88.69M-62.13M-56.60M-43.02M-33.87M-22.97M-13.21M
Earnings per share
Basic EPS
-0.57-1.48-3.44-3.09-4.91-93.73-98.58-24.76-14.24
Diluted EPS
-0.57-1.48-3.44-3.09-4.91-93.73-98.58-24.76-14.24
Data sourceData sourceData sourceData sourceData sourceData sourceData source